Table 5.
Heavy drinkers | Nonheavy drinkers | |||||||
---|---|---|---|---|---|---|---|---|
MnSOD TT | MnSOD TC + CC | MnSOD TT | MnSOD TC + CC | |||||
GPX1 | GPX1 | GPX1 | GPX1 | GPX1 | GPX1 | GPX1 | GPX1 | |
CC [A] | CT [B] | CC [C] | CT [D] | CC [A] | CT [B] | CC [C] | CT [D] | |
Parameters | (n = 81) | (n = 7) | (n = 15) | (n = 5) | (n = 66) | (n = 8) | (n = 25) | (n = 7) |
Immunological tests | ||||||||
CD3+ cells (%) | 65.6 ± 9.7 | 68.5 ± 7.4 | 65.4 ± 9.6 | 69.0 ± 1.8 | 62.5 ± 7.7 | 65.5 ± 8.0 | 66.4 ± 8.6 | 63.4 ± 15.0 |
CD4+ cells (%) | 36.2 ± 9.4 | 39.7 ± 7.7 | 32.6 ± 7.9 | 39.3 ± 8.2 | 32.5 ± 7.9 | 32.8 ± 7.6 | 30.6 ± 8.1 | 30.0 ± 11.0 |
CD8+ cells (%) | 22.8 ± 7.0 | 22.1 ± 4.5 | 21.1 ± 5.1 | 21.4 ± 6.3 | 23.2 ± 5.6 | 23.5 ± 5.4 | 27.3 ± 8.1 | 26.0 ± 7.7 |
CD19+ cells (%) | 10.8 ± 4.2 | 10.9 ± 4.2 | 12.1 ± 4.1 | 16.8 ± 4.2a | 12.3 ± 4.7 | 12.1 ± 2.3 | 11.7 ± 4.8 | 9.8 ± 3.3 |
IgG (mg/dl) | 1131 ± 216 | 1020 ± 343 | 1089 ± 228 | 1262 ± 381 | 1234 ± 274 | 1019 ± 106 | 1240 ± 209 | 1194 ± 223 |
IgM (mg/dl) | 89 ± 44 | 106 ± 53 | 79 ± 30 | 116 ± 53 | 97 ± 41 | 118 ± 54 | 134 ± 57a | 142 ± 105 |
IL‐2R (U/l) | 365 ± 131 | 361 ± 115 | 383 ± 159 | 500 ± 172 | 380 ± 161 | 337 ± 131 | 334 ± 112 | 332 ± 108 |
IL‐6 (ng/ml) | 3.9 ± 2.1 | 3.5 ± 1.8 | 4.4 ± 1.9 | 5.3 ± 2.1 | 3.4 ± 2.0 | 4.2 ± 2.8 | 2.7 ± 1.2 | 3.0 ± 2.0 |
IL‐8 (ng/ml) | 10.5 ± 5.0 | 9.7 ± 3.8 | 10.3 ± 5.9 | 10.2 ± 2.8 | 9.4 ± 5.3 | 9.6 ± 9.4 | 7.6 ± 3.1 | 12.5 ± 11.2 |
IL‐10 (ng/ml) | 1.9 ± 1.1 | 1.9 ± 0.7 | 2.0 ± 0.7 | 2.1 ± 1.3 | 1.9 ± 1.3 | 1.7 ± 1.1 | 1.6 ± 1.0 | 1.4 ± 1.1 |
TNF‐α (pg/ml) | 10.4 ± 8.7 | 7.9 ± 2.6 | 6.9 ± 2.1 | 9.3 ± 2.0 | 10.4 ± 9.2 | 10.3 ± 5.8 | 8.4 ± 4.4 | 18.1 ± 16.8 |
The alphabet in the square bracket indicates the group of the study.
P <0.05, compared with Group A in the heavy drinkers or nonheavy drinkers, respectively.
CD, cluster differentiation; Ig, immunoglobulin; IL, interleukin; TNF, tumor necrosis factor.